File(s) stored somewhere else
Please note: Linked content is NOT stored on La Trobe and we can't guarantee its availability, quality, security or accept any liability.
Improving function in people with hip-related pain: a systematic review and meta-analysis of physiotherapist-led interventions for hip-related pain
journal contributionposted on 05.11.2020, 22:35 authored by Joanne KempJoanne Kemp, Andrea MoslerAndrea Mosler, Harvi HartHarvi Hart, Mario Bizzini, Steven ChangSteven Chang, Mark ScholesMark Scholes, Adam SemciwAdam Semciw, Kay CrossleyKay Crossley
ObjectiveTo report the effectiveness of physiotherapist-led interventions in improving pain and function in young and middle-aged adults with hip-related pain.DesignSystematic review and meta-analysis.Data sourcesA comprehensive, reproducible search strategy was performed on five databases in May 2019. Reference lists and grey literature were also searched.Eligibility criteria for selecting studiesPopulation: people aged ≥18 years with hip-related pain (with or without a diagnosis of femoroacetabular impingement syndrome). Intervention(s): physiotherapist-led interventions for hip pain. Comparators: sham treatment, no treatment or other treatment (eg, hip arthroscopic surgery). Outcomes: primary outcomes included patient-reported hip pain and function. Secondary outcomes included physical function measures.Results1722 papers were identified. After exclusion criteria were applied, 14 studies were included for analysis. They had varied risk of bias. There were no full-scale placebo-controlled randomised controlled trials (RCTs) of physiotherapist-led treatment. Pooled effects ranged from moderate effects (0.67 (95% CI 0.07 to 1.26)) favouring physiotherapist-led intervention over no treatment post-arthroscopy, to weak effects (−0.32 (95% CI 0.57 to 0.07)) favouring hip arthroscopy over physiotherapist-led treatment.ConclusionPhysiotherapist-led interventions might improve pain and function in young and middle-aged adults with hip-related pain, however full-scale high-quality RCT studies are required.PROSPERO registration numberCRD42018089088.